WASHINGTON, D.C.—Targeted renal therapy (TRT) involving intrarenal administration of fenoldopam is safe and feasible in patients undergoing angiographic procedures, even in patients at elevated risk of suffering from contrast-induced nephropathy (CIN).
WASHINGTON, D.C.—Tunneled dialysis catheters may be implanted without a sheath to limit the size of the venotomy and thus the potential for bleeding following catheter placement, according to a pilot study.
DENVER—Close surgical margins in radical prostatectomy specimens could place patients at increased risk of PSA failure, according to a study that may challenge conventional wisdom.
In the recent market downturn, small stocks have been hit particularly hard. During the 12 months ending in March, the average small-cap fund lost 11.6%, lagging large-cap funds by more than nine percentage points.
WASHINGTON, D.C.—Restenting and angioplasty are both highly effective for treating renal artery in-stent stenosis, according to findings presented here at the Society of Interventional Radiology’s 33rd Annual Scientific Meeting.
Advanced kidney dysfunction independently predicts sudden cardiac death among women with coronary heart disease (CHD).
WASHINGTON, D.C.—A “halo sign” is a common delayed finding following radiofrequency ablation (RFA) of kidney tumors, according to researchers at the University of Toronto.
More than half of African Americans with hypertensive CKD will experience renal disease progression long-term despite tight BP control with drugs that block the renin-angiotensin system (RAS).
CHICAGO—Revascularization provides no advantage over medical treatment for renal function in patients with renal artery stenosis (RAS), data suggest.
Treatment with n-3 polyunsaturated acids (PUFA) may help hemodialysis (HD) patients lower serum triglyceride levels, according to a report in Nephrology Dialysis Transplantation (2008; published online ahead of print).
